What happens when you take phenytoin with calcium?
The phenytoin-calcium interaction is actually two interactions stacked on top of each other, and it is helpful to take them in turn.
The first is an absorption problem in the gut. Calcium-containing antacids (Tums, Maalox, Mylanta with calcium), calcium carbonate or citrate supplements, and to some extent calcium-rich dairy products can physically bind phenytoin in the gastrointestinal tract, forming a poorly absorbed chelate. Studies and case reports have documented falls of 20 to 40 percent in phenytoin serum levels when the two are taken at the same time, sometimes enough to allow seizure breakthrough. Phenytoin is also itself poorly soluble and absorbed unpredictably, which amplifies the effect.
The second is a downstream calcium-status problem. Phenytoin induces CYP3A4 and CYP24A1, which accelerate the breakdown of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D into inactive metabolites. Less active vitamin D means less efficient active calcium absorption from the small intestine. On top of that, lab studies in Caco-2 intestinal cells have shown that phenytoin itself directly inhibits the active transcellular calcium-transport pathway under physiologic calcium conditions. The end result is that even with normal dietary calcium intake, long-term phenytoin users tend to absorb calcium less efficiently and slowly drift toward low-normal or frankly low serum calcium, with compensatory rises in parathyroid hormone (PTH) and bone turnover.
Why is this important?
The acute absorption interaction matters because phenytoin has a narrow therapeutic window. Levels below roughly 10 micrograms per milliliter often fail to control seizures, and the nonlinear (Michaelis-Menten) kinetics of phenytoin mean that small changes in absorption can produce disproportionate changes in serum concentration. A patient who has been stable on phenytoin for years and then starts a calcium-containing antacid for reflux or a calcium supplement for bone health can find their seizures returning without an obvious explanation.
The chronic, downstream interaction matters because reduced calcium absorption combined with phenytoin-driven vitamin D catabolism is the central engine of anticonvulsant-induced bone disease — osteomalacia in adults, rickets in growing children, and increased fracture risk overall. Studies have measured roughly a 1.2 to 2.4 times higher fracture rate in patients on long-term enzyme-inducing anticonvulsants compared with the general population.
What should you do?
Separate the two doses. If you need a calcium supplement or a calcium-containing antacid while on phenytoin, take phenytoin on its own and wait at least 2 hours (some pharmacists suggest 4 hours where possible) before taking the calcium. If you take phenytoin with dinner, calcium can be taken at breakfast or at bedtime instead. Try not to take phenytoin with milk or yogurt-heavy meals.
Beyond timing, do not avoid calcium — long-term phenytoin users typically need more calcium, not less, because of the chronic absorption and metabolic changes. Most adults on phenytoin should aim for total daily calcium intake of around 1,000 to 1,200 mg from food and supplements combined, alongside vitamin D3 supplementation (often 1,000 to 2,000 IU per day) to maintain adequate 25(OH)D levels.
Ask your prescriber to monitor serum calcium, 25-hydroxyvitamin D, and ideally PTH and alkaline phosphatase periodically. Track calcium and antacid use in Pilora alongside your phenytoin doses so it is clear how doses are spaced. If your phenytoin level has dropped without an obvious explanation, calcium-related chelation is one of the first things to check.
Which specific products are affected?
On the drug side, this applies to all forms of phenytoin (Dilantin, Phenytek, generics) and to a smaller extent fosphenytoin when used orally. Other anticonvulsants like carbamazepine and oxcarbazepine show the same direction of effect on bone metabolism but generally less direct absorption chelation with calcium.
On the calcium side, the absorption interaction is strongest with calcium carbonate (Tums, Caltrate, Os-Cal), which requires acid for dissolution and is often taken in 500 to 1,000 mg doses. Calcium citrate (Citracal) is somewhat less acid-dependent but still chelates phenytoin if taken at the same time. Calcium-containing antacids and calcium fortifiers in foods can also reduce phenytoin absorption. Multivitamins with calcium, prenatal vitamins, and "bone health" formulas all qualify.
Tube feeds are a special case worth mentioning: phenytoin is notoriously hard to absorb when given through a feeding tube alongside enteral nutrition formulas (which are calcium- and protein-rich). Standard practice is to hold tube feeds for an hour before and after phenytoin doses.
The bottom line
Calcium products can bind phenytoin in the gut and drop its serum levels, while phenytoin itself impairs calcium absorption over time via vitamin D catabolism and direct effects on enterocyte transport. Separate doses by at least 2 hours, keep calcium and vitamin D intake adequate for bone protection, and have your phenytoin level checked if you add or change a calcium product.